Cargando…

Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS

Patients with severe haemophilia A experience frequent and spontaneous bleeding, causing debilitating damage to joints and decreasing quality of life. Prophylaxis with factor VIII (FVIII) reduces joint damage if initiated early. Circulating FVIII levels may be influenced by endogenous von Willebrand...

Descripción completa

Detalles Bibliográficos
Autores principales: Lalezari, S, Martinowitz, U, Windyga, J, Enriquez, M M, Delesen, H, Schwartz, L, Scharrer, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233978/
https://www.ncbi.nlm.nih.gov/pubmed/24252058
http://dx.doi.org/10.1111/hae.12294
_version_ 1782344785198055424
author Lalezari, S
Martinowitz, U
Windyga, J
Enriquez, M M
Delesen, H
Schwartz, L
Scharrer, I
author_facet Lalezari, S
Martinowitz, U
Windyga, J
Enriquez, M M
Delesen, H
Schwartz, L
Scharrer, I
author_sort Lalezari, S
collection PubMed
description Patients with severe haemophilia A experience frequent and spontaneous bleeding, causing debilitating damage to joints and decreasing quality of life. Prophylaxis with factor VIII (FVIII) reduces joint damage if initiated early. Circulating FVIII levels may be influenced by endogenous von Willebrand factor (VWF), a chaperone protein that binds and stabilizes FVIII. The aim of this study was to determine whether endogenous VWF antigen (VWF:Ag) levels are correlated with FVIII pharmacokinetic (PK) parameters and clinical outcomes in patients with severe haemophilia A. Previously treated, non-inhibitor patients in a multinational, randomized, double-blind, Ph II study received prophylaxis with once-weekly BAY 79-4980 (35 IU kg(−1)) or thrice-weekly recombinant sucrose-formulated FVIII (rFVIII-FS; 25 IU kg(−1)). PK parameters were evaluated at weeks 1 and 26. The number of bleeds per patient during the study was captured as part of the core efficacy endpoint. Spearman rank correlations assessed relationships of VWF:Ag levels with patient age, PK and annualized bleeding rate. Of 131 study patients (aged 13−64 years; BAY 79-4980, n = 63; rFVIII-FS, n = 68), 27 (21%; n = 15 and 12 respectively) were evaluable for PK assessment. Baseline VWF:Ag levels correlated with patient age (P < 0.0001). There was no significant difference in PK results between treatments; thus, PK parameters and VWF levels of all patients were analysed together. AUC(norm) and T(1/2) significantly increased with increased VWF:Ag (P < 0.001); clearance significantly decreased with increased VWF:Ag (P = 0.002). Annualized bleeding rate in patients treated with 3× per week rFVIII-FS significantly correlated with VWF:Ag and age (P = 0.038 and 0.021 respectively). PK parameters as well as the clinical outcome significantly correlated with endogenous VWF:Ag. The improved clinical outcome in subjects with high VWF:Ag levels may be explained by VWF:Ag influence on FVIII PK.
format Online
Article
Text
id pubmed-4233978
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42339782014-12-03 Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS Lalezari, S Martinowitz, U Windyga, J Enriquez, M M Delesen, H Schwartz, L Scharrer, I Haemophilia Original Articles Patients with severe haemophilia A experience frequent and spontaneous bleeding, causing debilitating damage to joints and decreasing quality of life. Prophylaxis with factor VIII (FVIII) reduces joint damage if initiated early. Circulating FVIII levels may be influenced by endogenous von Willebrand factor (VWF), a chaperone protein that binds and stabilizes FVIII. The aim of this study was to determine whether endogenous VWF antigen (VWF:Ag) levels are correlated with FVIII pharmacokinetic (PK) parameters and clinical outcomes in patients with severe haemophilia A. Previously treated, non-inhibitor patients in a multinational, randomized, double-blind, Ph II study received prophylaxis with once-weekly BAY 79-4980 (35 IU kg(−1)) or thrice-weekly recombinant sucrose-formulated FVIII (rFVIII-FS; 25 IU kg(−1)). PK parameters were evaluated at weeks 1 and 26. The number of bleeds per patient during the study was captured as part of the core efficacy endpoint. Spearman rank correlations assessed relationships of VWF:Ag levels with patient age, PK and annualized bleeding rate. Of 131 study patients (aged 13−64 years; BAY 79-4980, n = 63; rFVIII-FS, n = 68), 27 (21%; n = 15 and 12 respectively) were evaluable for PK assessment. Baseline VWF:Ag levels correlated with patient age (P < 0.0001). There was no significant difference in PK results between treatments; thus, PK parameters and VWF levels of all patients were analysed together. AUC(norm) and T(1/2) significantly increased with increased VWF:Ag (P < 0.001); clearance significantly decreased with increased VWF:Ag (P = 0.002). Annualized bleeding rate in patients treated with 3× per week rFVIII-FS significantly correlated with VWF:Ag and age (P = 0.038 and 0.021 respectively). PK parameters as well as the clinical outcome significantly correlated with endogenous VWF:Ag. The improved clinical outcome in subjects with high VWF:Ag levels may be explained by VWF:Ag influence on FVIII PK. Blackwell Publishing Ltd 2014-01 2013-11-20 /pmc/articles/PMC4233978/ /pubmed/24252058 http://dx.doi.org/10.1111/hae.12294 Text en © 2013 The Authors. Haemophilia Published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Lalezari, S
Martinowitz, U
Windyga, J
Enriquez, M M
Delesen, H
Schwartz, L
Scharrer, I
Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS
title Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS
title_full Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS
title_fullStr Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS
title_full_unstemmed Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS
title_short Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS
title_sort correlation between endogenous vwf:ag and pk parameters and bleeding frequency in severe haemophilia a subjects during three-times-weekly prophylaxis with rfviii-fs
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233978/
https://www.ncbi.nlm.nih.gov/pubmed/24252058
http://dx.doi.org/10.1111/hae.12294
work_keys_str_mv AT lalezaris correlationbetweenendogenousvwfagandpkparametersandbleedingfrequencyinseverehaemophiliaasubjectsduringthreetimesweeklyprophylaxiswithrfviiifs
AT martinowitzu correlationbetweenendogenousvwfagandpkparametersandbleedingfrequencyinseverehaemophiliaasubjectsduringthreetimesweeklyprophylaxiswithrfviiifs
AT windygaj correlationbetweenendogenousvwfagandpkparametersandbleedingfrequencyinseverehaemophiliaasubjectsduringthreetimesweeklyprophylaxiswithrfviiifs
AT enriquezmm correlationbetweenendogenousvwfagandpkparametersandbleedingfrequencyinseverehaemophiliaasubjectsduringthreetimesweeklyprophylaxiswithrfviiifs
AT delesenh correlationbetweenendogenousvwfagandpkparametersandbleedingfrequencyinseverehaemophiliaasubjectsduringthreetimesweeklyprophylaxiswithrfviiifs
AT schwartzl correlationbetweenendogenousvwfagandpkparametersandbleedingfrequencyinseverehaemophiliaasubjectsduringthreetimesweeklyprophylaxiswithrfviiifs
AT scharreri correlationbetweenendogenousvwfagandpkparametersandbleedingfrequencyinseverehaemophiliaasubjectsduringthreetimesweeklyprophylaxiswithrfviiifs